stockrow
Saturday 7 November 2026
Export GMRS’s income statement to Excel — free account
GMR Solutions Inc.
GMRS Healthcare Medical Care Facilities
12.42
0.09
−0.72%
Follow GMRS
Alert me
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+1 more quarter Free account |
19.70 | — | 19.70 | 19.70 |
P/S ratio |
0.00 | — | 0.00 | 0.17 | |
P/FCF ratio |
0.00 | — | 0.00 | 5.14 | |
P/Operating CF |
4.98 | — | 4.98 | 10.94 | |
P/B ratio |
3.01 | — | 3.01 | 1.23 | |
Price to Tangible BV |
0.00 | — | 0.00 | 0.00 | |
EV/Sales |
0.00 | — | 0.00 | 0.88 | |
EV/EBITDA |
0.00 | — | 0.00 | 5.01 | |
EV/Operating CF |
0.00 | — | 0.00 | 11.56 | |
EV/FCF |
0.00 | — | 0.00 | 26.77 | |
Quick Ratio |
— | 1.60 | 1.48 | 1.58 | |
Current Ratio |
— | 2.00 | 1.87 | 2.01 | |
Net Debt/EBITDA |
0.00 | 0.00 | 15.81 | 29.94 | |
Debt/Assets |
0.00% | 68.44% | 69.69% | 60.48% | |
Debt/Equity |
0.00 | 25.08 | 24.05 | 5.69 | |
Asset Turnover |
— | — | — | 1.55 | |
Operating CF/Net income |
0.74 | — | 3.04 | (0.77) | |
Capex/Depreciation |
(0.76) | — | (0.82) | (0.91) | |
Interest Coverage |
2.22 | — | 2.63 | 0.74 | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
51.50% | — | 52.83% | 62.04% | |
Intangible Assets out of Total Assets |
0.00 | 0.45 | 0.46 | 0.45 | |
Share Based Compensation of Revenue |
0.06% | — | (0.01%) | 8.90% | |
Graham Net Nets |
(8.01) | — | (8.01) | (4.76) | |
Graham Number |
0.00 | — | 0.00 | 14.91 | |
Earnings Yield |
5.08% | — | 5.08% | 5.08% | |
Free Cash Flow Yield |
0.00% | — | 0.00% | 19.44% | |
Revenue per Share |
31.65 | — | 31.80 | 23.78 | |
Operating CF per Share |
0.64 | — | 2.81 | 1.41 | |
Capex per Share |
(1.28) | — | (1.40) | (1.16) | |
Free Cash Flow per Share |
(0.64) | — | 1.41 | 0.26 | |
Cash per Share |
0.00 | 0.00 | 9.30 | 6.70 | |
Shareholders Equity per Share |
0.00 | 0.00 | 4.64 | 12.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 4.64 | 12.59 | |
Free Cash Flow |
(29.18) | — | 64.61 | 16.06 | |
Working Capital |
— | 1,067.65 | 926.85 | 1,017.13 | |
Capital Expenditures |
(58.51) | — | (64.14) | (72.53) | |
Net Current Asset Value |
0.00 | (5,145.81) | (5,133.14) | (4,617.02) | |
EV/EBIT |
0.00 | — | 0.00 | 7.26 | |
Capex to Sales |
0.04 | — | 0.04 | 0.05 | |
Price to Operating Income |
0.00 | — | 0.00 | 1.40 | |
| Other line items | |||||
Average Assets |
— | — | — | 3,714.63 |
Columns are period end dates · fundamentals updated 26 Oct 2026